ANKTIVA vs AVOPEF

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. ANKTIVA and AVOPEF are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ANKTIVA	AVOPEF
Rating	New	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	nogapendekin alfa inbakicept-pmln	ETOPOSIDE
Manufacturer	Altor Bioscience, LLC, An Indirect Wholly-Owned Su	Avyxa Holdings
Dosage forms	Solution	Injectable
Drug class	Interleukin-15 Receptor Agonist	Topoisomerase Inhibitor
Boxed warning	None	Boxed warning
Treats	Urinary Bladder Neoplasms	Urinary Bladder Neoplasms, Brain Neoplasms, Lung Neoplasms

anktiva avopef

Rating

New

Pharmacy pays

—

Type

Active ingredient

nogapendekin alfa inbakicept-pmln

ETOPOSIDE

Manufacturer

Altor Bioscience, LLC, An Indirect Wholly-Owned Su

Avyxa Holdings

Dosage forms

Solution

Injectable

Drug class

Interleukin-15 Receptor Agonist

Topoisomerase Inhibitor

Boxed warning

None

Boxed warning

Treats

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms, Brain Neoplasms, Lung Neoplasms

Frequently asked questions

What is the difference between Anktiva and Avopef?

Anktiva contains Nogapendekin Alfa Inbakicept-Pmln, while Avopef contains Etoposide — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.